blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3347015

EP3347015 - FASORACETAM FOR TREATING CONDUCT DISORDER [Right-click to bookmark this link]
Former [2018/29]METHODS OF DIAGNOSING AND TREATING CONDUCT DISORDER
[2021/09]
StatusNo opposition filed within time limit
Status updated on  26.08.2022
Database last updated on 31.03.2026
FormerThe patent has been granted
Status updated on  17.09.2021
FormerGrant of patent is intended
Status updated on  20.06.2021
FormerExamination is in progress
Status updated on  25.05.2021
FormerGrant of patent is intended
Status updated on  14.02.2021
FormerExamination is in progress
Status updated on  15.04.2020
FormerRequest for examination was made
Status updated on  15.06.2018
FormerThe international publication has been made
Status updated on  21.03.2017
Most recent event   Tooltip13.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 16.10.2024  [2024/42]
Applicant(s)For all designated states
The Children's Hospital of Philadelphia
3401 Civic Center Boulevard
Philadelphia, PA 19104 / US
[2021/27]
Former [2021/11]For all designated states
The Children's Hospital of Philadelphia
34th Street & Civic Center Boulevard
Philadelphia, PA 19104 / US
Former [2018/29]For all designated states
The Children's Hospital of Philadelphia
34th and Civic Center Boulevard
Philadelphia, PA 19104 / US
Inventor(s)01 / HAKONARSON, Hakon
1877 Covered Bridge Road
Malvern, Pennsylvania 19355 / US
02 / KAO, Charlly
4619 Chester Avenue
Apt. B202
Philadelphia, PA 19143 / US
 [2021/26]
Former [2018/29]01 / HAKONARSON, Hakon
1877 Covered Bridge Road
Malvern, Pennsylvania 19355 / US
02 / KAO, Charlly
4601 Chester Avenue
Apt 2D
Philadelphia, Pennsylvania 19143 / US
Representative(s)Høiberg P/S
Adelgade 12
1304 Copenhagen K / DK
[2018/29]
Application number, filing date16767115.507.09.2016
[2018/29]
WO2016US50580
Priority number, dateUS201562215628P08.09.2015         Original published format: US 201562215628 P
US201562215633P08.09.2015         Original published format: US 201562215633 P
US201562215636P08.09.2015         Original published format: US 201562215636 P
US201562215673P08.09.2015         Original published format: US 201562215673 P
[2018/29]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017044502
Date:16.03.2017
Language:EN
[2017/11]
Type: A1 Application with search report 
No.:EP3347015
Date:18.07.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 16.03.2017 takes the place of the publication of the European patent application.
[2018/29]
Type: B1 Patent specification 
No.:EP3347015
Date:20.10.2021
Language:EN
[2021/42]
Search report(s)International search report - published on:EP16.03.2017
ClassificationIPC:A61K31/454, A61P25/00, A61P25/18, C12Q1/6883
[2021/09]
CPC:
A61K31/454 (EP,CN,IL,US); A61K45/06 (IL,US); A61P25/00 (EP,CN,IL);
A61P25/22 (EP,IL); A61P25/28 (CN,IL); C12Q1/6883 (IL,US);
A61K2300/00 (IL); C12Q2600/156 (IL,US); C12Q2600/158 (IL,US) (-)
C-Set:
A61K31/454, A61K2300/00 (EP,US)
Former IPC [2018/29]A61K31/454, A61P25/00, A61P25/28
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/29]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:FASORACETAM ZUR BEHANDLUNG VON VERHALTENSSTÖRUNGEN[2021/26]
English:FASORACETAM FOR TREATING CONDUCT DISORDER[2021/26]
French:FASORACETAM POUR LE TRAITEMENT DU TROUBLES DES CONDUITES[2021/26]
Former [2018/29]VERFAHREN ZUR DIAGNOSE UND BEHANDLUNG VON VERHALTENSSTÖRUNGEN
Former [2018/29]METHODS OF DIAGNOSING AND TREATING CONDUCT DISORDER
Former [2018/29]MÉTHODES DE DIAGNOSTIC ET DE TRAITEMENT DU TROUBLES DES CONDUITES
Entry into regional phase05.04.2018National basic fee paid 
05.04.2018Designation fee(s) paid 
05.04.2018Examination fee paid 
Examination procedure05.04.2018Examination requested  [2018/29]
05.04.2018Date on which the examining division has become responsible
29.10.2018Amendment by applicant (claims and/or description)
20.04.2020Despatch of a communication from the examining division (Time limit: M06)
01.07.2020Reply to a communication from the examining division
15.02.2021Communication of intention to grant the patent
21.05.2021Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
21.06.2021Communication of intention to grant the patent
17.08.2021Fee for grant paid
17.08.2021Fee for publishing/printing paid
17.08.2021Receipt of the translation of the claim(s)
Divisional application(s)EP21201653.9  / EP3964213
EP24162567.2  / EP4410289
Opposition(s)21.07.2022No opposition filed within time limit [2022/39]
Fees paidRenewal fee
25.09.2018Renewal fee patent year 03
13.09.2019Renewal fee patent year 04
14.09.2020Renewal fee patent year 05
13.09.2021Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU07.09.2016
AL20.10.2021
AT20.10.2021
CY20.10.2021
CZ20.10.2021
EE20.10.2021
FI20.10.2021
HR20.10.2021
LT20.10.2021
LV20.10.2021
MC20.10.2021
MK20.10.2021
MT20.10.2021
NL20.10.2021
PL20.10.2021
RO20.10.2021
RS20.10.2021
SE20.10.2021
SI20.10.2021
SK20.10.2021
SM20.10.2021
TR20.10.2021
BG20.01.2022
NO20.01.2022
GR21.01.2022
IS20.02.2022
PT21.02.2022
[2024/42]
Former [2024/29]HU07.09.2016
AL20.10.2021
AT20.10.2021
CY20.10.2021
CZ20.10.2021
EE20.10.2021
FI20.10.2021
HR20.10.2021
LT20.10.2021
LV20.10.2021
MC20.10.2021
MK20.10.2021
NL20.10.2021
PL20.10.2021
RO20.10.2021
RS20.10.2021
SE20.10.2021
SI20.10.2021
SK20.10.2021
SM20.10.2021
TR20.10.2021
BG20.01.2022
NO20.01.2022
GR21.01.2022
IS20.02.2022
PT21.02.2022
Former [2024/27]HU07.09.2016
AL20.10.2021
AT20.10.2021
CY20.10.2021
CZ20.10.2021
EE20.10.2021
FI20.10.2021
HR20.10.2021
LT20.10.2021
LV20.10.2021
MC20.10.2021
MK20.10.2021
NL20.10.2021
PL20.10.2021
RO20.10.2021
RS20.10.2021
SE20.10.2021
SI20.10.2021
SK20.10.2021
SM20.10.2021
BG20.01.2022
NO20.01.2022
GR21.01.2022
IS20.02.2022
PT21.02.2022
Former [2024/21]HU07.09.2016
AL20.10.2021
AT20.10.2021
CY20.10.2021
CZ20.10.2021
EE20.10.2021
FI20.10.2021
HR20.10.2021
LT20.10.2021
LV20.10.2021
MC20.10.2021
NL20.10.2021
PL20.10.2021
RO20.10.2021
RS20.10.2021
SE20.10.2021
SI20.10.2021
SK20.10.2021
SM20.10.2021
BG20.01.2022
NO20.01.2022
GR21.01.2022
IS20.02.2022
PT21.02.2022
Former [2024/18]HU07.09.2016
AL20.10.2021
AT20.10.2021
CZ20.10.2021
EE20.10.2021
FI20.10.2021
HR20.10.2021
LT20.10.2021
LV20.10.2021
MC20.10.2021
NL20.10.2021
PL20.10.2021
RO20.10.2021
RS20.10.2021
SE20.10.2021
SI20.10.2021
SK20.10.2021
SM20.10.2021
BG20.01.2022
NO20.01.2022
GR21.01.2022
IS20.02.2022
PT21.02.2022
Former [2023/22]AL20.10.2021
AT20.10.2021
CZ20.10.2021
EE20.10.2021
FI20.10.2021
HR20.10.2021
LT20.10.2021
LV20.10.2021
MC20.10.2021
NL20.10.2021
PL20.10.2021
RO20.10.2021
RS20.10.2021
SE20.10.2021
SI20.10.2021
SK20.10.2021
SM20.10.2021
BG20.01.2022
NO20.01.2022
GR21.01.2022
IS20.02.2022
PT21.02.2022
Former [2023/01]AL20.10.2021
AT20.10.2021
CZ20.10.2021
EE20.10.2021
FI20.10.2021
HR20.10.2021
LT20.10.2021
LV20.10.2021
NL20.10.2021
PL20.10.2021
RO20.10.2021
RS20.10.2021
SE20.10.2021
SI20.10.2021
SK20.10.2021
SM20.10.2021
BG20.01.2022
NO20.01.2022
GR21.01.2022
IS20.02.2022
PT21.02.2022
Former [2022/49]AL20.10.2021
AT20.10.2021
CZ20.10.2021
EE20.10.2021
FI20.10.2021
HR20.10.2021
LT20.10.2021
LV20.10.2021
NL20.10.2021
PL20.10.2021
RO20.10.2021
RS20.10.2021
SE20.10.2021
SK20.10.2021
SM20.10.2021
BG20.01.2022
NO20.01.2022
GR21.01.2022
IS20.02.2022
PT21.02.2022
Former [2022/35]AT20.10.2021
CZ20.10.2021
EE20.10.2021
FI20.10.2021
HR20.10.2021
LT20.10.2021
LV20.10.2021
NL20.10.2021
PL20.10.2021
RO20.10.2021
RS20.10.2021
SE20.10.2021
SK20.10.2021
SM20.10.2021
BG20.01.2022
NO20.01.2022
GR21.01.2022
IS20.02.2022
PT21.02.2022
Former [2022/34]AT20.10.2021
EE20.10.2021
FI20.10.2021
HR20.10.2021
LT20.10.2021
LV20.10.2021
NL20.10.2021
PL20.10.2021
RO20.10.2021
RS20.10.2021
SE20.10.2021
SM20.10.2021
BG20.01.2022
NO20.01.2022
GR21.01.2022
IS20.02.2022
PT21.02.2022
Former [2022/33]AT20.10.2021
FI20.10.2021
HR20.10.2021
LT20.10.2021
LV20.10.2021
NL20.10.2021
PL20.10.2021
RS20.10.2021
SE20.10.2021
SM20.10.2021
BG20.01.2022
NO20.01.2022
GR21.01.2022
IS20.02.2022
PT21.02.2022
Former [2022/25]AT20.10.2021
FI20.10.2021
HR20.10.2021
LT20.10.2021
LV20.10.2021
NL20.10.2021
PL20.10.2021
RS20.10.2021
SE20.10.2021
BG20.01.2022
NO20.01.2022
GR21.01.2022
IS20.02.2022
PT21.02.2022
Former [2022/24]AT20.10.2021
FI20.10.2021
HR20.10.2021
LT20.10.2021
LV20.10.2021
NL20.10.2021
PL20.10.2021
RS20.10.2021
SE20.10.2021
BG20.01.2022
GR21.01.2022
IS20.02.2022
PT21.02.2022
Former [2022/23]AT20.10.2021
FI20.10.2021
HR20.10.2021
LT20.10.2021
LV20.10.2021
PL20.10.2021
RS20.10.2021
BG20.01.2022
PT21.02.2022
Former [2022/22]AT20.10.2021
FI20.10.2021
LT20.10.2021
RS20.10.2021
BG20.01.2022
Former [2022/21]AT20.10.2021
RS20.10.2021
BG20.01.2022
Former [2022/19]BG20.01.2022
Cited inInternational search[XI] US2012149677  (DUDKIN VADIM Y et al.)
 [X] US2010216734  (BARLOW CARROLEE et al.)
 [I]   NAVARRO J F ET AL: "P.1.d.006 Effects of LY379268, a selective agonist of mGlu2/3 receptors, on isolation-induced aggression in male mice", EUROPEAN NEUROPSYCHOPHARMACOLOGY, ELSEVIER SCIENCE PUBLISHERS BV, AMSTERDAM, NL, vol. 18, 1 August 2008 (2008-08-01), pages S252, XP025610808, ISSN: 0924-977X, [retrieved on 20080801], DOI: 10.1016/S0924-977X(08)70321-3

DOI:   http://dx.doi.org/10.1016/S0924-977X(08)70321-3
 [A]   MALYKH ANDREI G ET AL: "Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders", DRUGS, ADIS INTERNATIONAL LTD, NZ, vol. 70, no. 3, 1 January 2010 (2010-01-01), pages 287 - 312, XP009162620, ISSN: 0012-6667, DOI: 10.2165/11319230-000000000-00000

DOI:   http://dx.doi.org/10.2165/11319230-000000000-00000
 [A]   KENNETH S. KENDLER ET AL: "Familial Influences on Conduct Disorder Reflect 2 Genetic Factors and 1 Shared Environmental Factor", JAMA PSYCHIATRY, vol. 70, no. 1, 1 January 2013 (2013-01-01), pages 78, XP055326562, ISSN: 2168-622X, DOI: 10.1001/jamapsychiatry.2013.267

DOI:   http://dx.doi.org/10.1001/jamapsychiatry.2013.267
by applicant  AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY: CONDUCT DISORDERS, 2013
   ERCAN ES ET AL., CHILD ADOLESC PSYCHIATRY MENT HEALTH., vol. 5, no. 1, 2011, pages 10
   NOCK MK ET AL., PSYCHOL. MED., vol. 36, no. 5, 2006, pages 699 - 710
   WASCHBUSCH DA ASSESSMENT, vol. 14, no. 1, 2007, pages 65 - 74
   SANSONE SM, J AUTISM DE DISORD, vol. 42, no. 7, 2012, pages 1377 - 1392
   AMERICAN ACADEMY OF CHILD ADOLESCENT PSYCHIATRY: CONDUCT DISORDERS, 2013
   TOTEJA N, INT J NEUROPSYCHOPHARMACOL, vol. 17, no. 7, 2014, pages 1095 - 105
   JAMES AC ADZ, PSYCHIATR TREAT, vol. 16, 2010, pages 63 - 75
   "Diagnostic and Statistical Manual of Mental Disorders", 2013
   SBANNON P, GENOME RESEARCH, vol. 13, 2003, pages 2498 - 2504
   SHANNON P ET AL., GENOME RESEARCH, vol. 13, 2003, pages 2498 - 250,1
   "International Classification of Diseases", article "Developmental disorders"
   HIROUCHI M ET AL., EUROPEAN JOURNAL OF PHARMACOLOGY, vol. 387, 2000, pages 9 - 17
   OKA M ET AL., BRAIN RESEARCH, vol. 754, 1997, pages 121 - 130
   MALYKH AG ET AL., DRUGS, vol. 70, no. 3, 2010, pages 287 - 312
   WANG K ET AL., COLD SPRING HARB PROTOC, June 2008 (2008-06-01)
   WA {G K ET AL., GENOME RES., vol. 17, no. 11, 2007, pages 1665 - 74
   ELIA ET AL., NATURE GENETICS, vol. 44, no. 1, 2012, pages 78 - 84
   WANG K ET AL., GENOME RES., vol. 17, no. 11, November 2007 (2007-11-01), pages 1665 - 74
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.